Showing results (1311-1320 of 1,365) with videos related to
Sort By:
Pageof 137
International Journal of Pharmaceutical Compounding|January 31, 2023
Basics: A Review: In Situ Gel Dosage Forms for Herbal Medicine DeliveryPutriana RachmawatiInternational Journal of Pharmaceutical Compounding|January 31, 2023
Advanced Compounding: Compounding with Microneedle Arrays, Part 3: Microneedle Array Development in the Literature and Quality Control of Microneedle ArraysLoyd V AllenInternational Journal of Pharmaceutical Compounding|October 20, 2025
Specific Features of Allergic Reaction to Metals: From Aetiology to PreventionMaria Zofia LisieckaInternational Journal of Pharmaceutical Compounding|October 20, 2025
The Physical Compatibility of Orphenadrine Citrate with 0.45% Sodium Chloride, Lactated Ringer's Solution, and Plasma-Lyte AChinenye G Ezema, Mitchell S Howard, Gabriella Baki, et al.International Journal of Pharmaceutical Compounding|October 20, 2025
SyrSpend® SF PH 4 as a Safe Vehicle for Extemporaneous Oral Suspensions: Microbiological Stability of Seven APIsCarolina Schettino Kegele, Eli Dijkers, Hudson PoloniniInternational Journal of Pharmaceutical Compounding|October 20, 2025
Microbiological and Physical Stability of Extemporaneous Oral Suspensions Compounded with SyrSpend® SF PH4Carolina Schettino Kegele, Eli Dijkers, Hudson PoloniniInternational Journal of Pharmaceutical Compounding|October 20, 2025
Physical Compatibility of Ertapenem and Meropenem in 0.45% Normal Saline and Plasma-Lyte ABerah Brown, Jacquelyn Schemmel, Justin P Reinert, et al.International Journal of Pharmaceutical Compounding|October 20, 2025
Development and Physical Stability Assessment of an Extemporaneous Formulation of Gabapentin LozengesMarisol López-Nieves, Jetzabel Delgado-Díaz, Sormarie Figueroa-Morales, et al.International Journal of Pharmaceutical Compounding|September 17, 2025
Antimicrobial Stability, pH, and Physical Appearance of Cardiovascular Drug Suspensions in SyrSpend® SF PH4: A Complementary EvaluationCarolina Schettino Kegele, Eli Dijkers, Hudson PoloniniInternational Journal of Pharmaceutical Compounding|September 17, 2025
Legal Challenges to Compounding Drugs for Weight LossBlinn E Combs, Brad HowardPageof 137